TrialAdvances in therapy2023

Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies.

Jonathan Barratt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.